---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-24-047141"
form_type: "8-K"
ticker: "CETX"
cik: "0001435064"
company_name: "CEMTREX INC"
filed_at: "2024-11-21T23:59:59+00:00"
generated_at: "2026-05-29T20:32:32.257532+00:00"
event_type: "other_material"
sentiment: "negative"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Cemtrex approves 1-for-35 reverse stock split effective Nov 26 to regain Nasdaq compliance

## Summary
- Reverse split ratio of 1-for-35; effective at 12:01 a.m. ET on November 26, 2024; CUSIP changes to 15130G881.
- Reason: To regain compliance with Nasdaq minimum $1 bid price; deficiency notice received June 14, 2024; compliance deadline December 11, 2024.
- Adjustable Warrants (19,026,954 shares at $0.7446 pre-split) will have exercise price reset to lowest VWAP 5 days before/after split; underlying shares significantly increased.
- Fractional shares: holders with at least one pre-split share get rounded up; others rounded down; no fractional shares issued.
- Board determined final ratio within range approved by stockholders on October 17, 2024; ticker symbol CETX unchanged.

## SEC filing metadata
- accession: 0001493152-24-047141
- form_type: 8-K
- ticker: CETX
- cik: 0001435064
- company_name: CEMTREX INC
- filed_at: 2024-11-21T23:59:59+00:00
- event_type: other_material
- sentiment: negative
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 3.03, 5.03, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1435064/000149315224047141/0001493152-24-047141-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1435064/000149315224047141/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-24-047141
- JSON: https://secwatch.observer/filing/0001493152-24-047141.json
- Plain text: https://secwatch.observer/filing/0001493152-24-047141.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.